JSE to contend with mixed Asian markets on Wednesday amid vaccine worries
The US, EU and SA have all decided to temporarily halt the rollout of the Johnson & Johnson vaccine due to blood clot concerns
14 April 2021 - 07:19
The JSE faces mixed Asian markets on Wednesday morning, with a generally positive tone on global markets undermined by the concern that vaccine rollouts may be delayed due to side effects from the Johnson & Johnson Covid-19 vaccine.
The US, EU and SA have decided to temporarily halt the vaccine due to incidents of severe blood clotting. The review is expected to take a few days..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.